Hopp til hovedinnhold

Reversibel cerebral vasokonstriksjons syndrom (RCVS)

Sist oppdatert: Sist revidert:
Sist revidert av:
  1. Ducros A, Bousser MG. Reversible cerebral vasoconstriction syndrome. Pract Neurol 2009; 9: 256-67. PMID: 19762885 PubMed  
  2. Elstner M, Linn J, Müller-Schunk S, Straube A. Reversible cerebral vasoconstriction syndrome: a complicated clinical course treated with intra-arterial application of nimodipine. Cephalalgia 2009; 29: 677-82. PMID: 19239677 PubMed  
  3. Ducros A. Reversible cerebral vasoconstriction syndrome. Lancet Neurol 2012; 11: 906-17. PMID: 22995694 PubMed  
  4. Tønsaas M, Johnsen SH, Seip M, Eldevik P. Diagnostiske utfordringer hos en mann med subaraknoidalblodning. Tidsskr Nor Laegeforen 2009; 129: 2490-2. PMID: 19997139 PubMed  
  5. Wiles KS, Nortley R, Siddiqui A, Holmes P, Nelson-Piercy C. Reversible cerebral vasoconstriction syndrome: a rare cause of postpartum headache. Pract Neurol. 2015 Apr;15(2):141-4 . pmid:25573342 PubMed  
  6. Imai M, Shimoda M, Oda S, Hoshikawa K, Osada T, Aoki R, Sunaga A. Reversible Cerebral Vasoconstriction Syndrome Patients with a History of Migraine: A Retrospective Case-control Study. Intern Med. 2022 Jul 14. doi: 10.2169/internalmedicine.9776-22. Epub ahead of print. PMID: 35831115 PubMed  
  7. English SW, Nasr DM. Thunderclap Headache and Cerebral Vasoconstriction Secondary to Pheochromocytoma. JAMA Neurol. 2019 Apr 1;76(4):502-503. PMID: 30801609 PubMed  
  8. Singhal AB, et al. Reversible cerebral vasoconstriction syndromes and primary angiitis of the central nervous system: clinical, imaging, and angiographic comparison. 2016. pmid:27043703 PubMed  
  9. Katz BS, et al. Clinical worsening in reversible cerebral vasoconstriction syndrome. JAMA Neurol. 2014; Jan;71(1): 68-73.. pmid:2419009 PubMed  
  10. Garg A, Starr M, Rocha M, Ortega-Gutierrez S. Predictors and outcomes of ischemic stroke in reversible cerebral vasoconstriction syndrome. J Neurol. 2021 Aug;268(8):3020-3025. PMID: 33646329. PubMed  
  11. Burton TM, Bushnell CD. Reversible Cerebral Vasoconstriction Syndrome. Stroke. 2019 Aug;50(8):2253-2258. PMID: 31272323 PubMed  
  12. Patel SD, Topiwala K, Saini V, Patel N, Pervez M, Al-Mufti F, Hassan AE, Khandelwal P, Starke RM. Hemorrhagic reversible cerebral vasoconstriction syndrome: A retrospective observational study. J Neurol. 2021 Feb;268(2):632-639. doi: 10.1007/s00415-020-10193-y. Epub 2020 Sep 7. PMID: 32894331. PubMed  
  13. Neeb L, et al. Spectrum of cerebral spinal fluid findings in patients with posterior reversible encephalopathy syndrome. J Neurol. 2015. pmid: 26477022 PubMed  
  14. Perillo T, Paolella C, Perrotta G, Serino A, Caranci F, Manto A. Reversible cerebral vasoconstriction syndrome: review of neuroimaging findings. Radiol Med. 2022 Sep;127(9):981-990. doi: 10.1007/s11547-022-01532-2. Epub 2022 Aug 6. PMID: 3593244 PubMed  
  15. Mills JN, Mehta V, Russin J, Amar AP, Rajamohan A, Mack WJ. Advanced imaging modalities in the detection of cerebral vasospasm. Neurol Res Int. 2013;2013:415960. doi: 10.1155/2013/415960. Epub 2013 Feb 6. PMID: 23476766 PubMed  
  16. Miller TR, Shivashankar R, Mossa-Basha M, Gandhi D. Reversible Cerebral Vasoconstriction Syndrome, Part 2: Diagnostic Work-Up, Imaging Evaluation, and Differential Diagnosis. AJNR Am J Neuroradiol. 2015 Sep;36(9):1580-8. PMID: 25614476 PubMed  
  17. Cho S, Lee MJ, Chung CS. Effect of Nimodipine Treatment on the Clinical Course of Reversible Cerebral Vasoconstriction Syndrome. Front Neurol. 2019 Jun 18;10:644. PMID: 31275233 PubMed  
  18. Silva DP, Soares MF, Almeida V, Fonseca AC. Chronic headache with vasospasm treated with nimodipine. J Neurol. 2019 Jun;266(6):1536-1538. PMID: 30911823 PubMed  
  19. Hawkes MA, Hlavnicka AA, Wainsztein NA. Reversible Cerebral Vasoconstriction Syndrome Responsive to Intravenous Milrinone. Neurocrit Care. 2019 Sep 30. PMID: 31571175 PubMed  
  20. Singhal AB, Topcuoglu MA.. Glucocorticoid-associated worsening in reversible cerebral vasoconstriction syndrome.. Neurology 2017. pmid:27940651 PubMed  
  21. Boitet R, de Gaalon S, Duflos C, Marin G, Mawet J, Burcin C, Roos C, Fiedler U, Bousser MG, Ducros A. . Long-Term Outcomes After Reversible Cerebral Vasoconstriction Syndrome. Stroke 2020; Feb;51(2):: 670-673. pmid:31842705 PubMed  
  22. Ling YH, Wang YF, Lirng JF, Fuh JL, Wang SJ, Chen SP. Post-reversible cerebral vasoconstriction syndrome headache. J Headache Pain. 2021 Mar 25;22(1):14. PMID: 33765906 PubMed  
  23. John S, Singhal AB, Calabrese L, Uchino K, Hammad T, Tepper S, Stillman M, Mills B, Thankachan T, Hajj-Ali RA. Long-term outcomes after reversible cerebral vasoconstriction syndrome. Cephalalgia. 2015 Jun 18. pii: 0333102415591507 . pmid:26088331 PubMed  
  24. Patel SD, Topiwala K, Otite Oliver F, Saber H, Panza G, Mui G, Liebeskind DS, Saver JL, Alberts M, Ducros A. Outcomes Among Patients With Reversible Cerebral Vasoconstriction Syndrome: A Nationwide United States Analysis. Stroke. 2021 Sep 2:STROKEAHA121034424. PMID: 34470494. PubMed  
  • Åse Mygland, spesialist i nevrologi, professor PhD
  • Unn Ljøstad, spesialist i nevrologi, professor PhD
  • Christian Lund, spesialist i nevrologi PhD
  • Titto Idicula, spesialist i nevrologi, PhD